TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 28-12-2015
AUM:
₹ 1,282 Cr
Expense Ratio
2.11%
Benchmark
NIFTY Pharma TRI
ISIN
INF277K018A5
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
100
Fund Manager
Meeta Shetty, Rajat Srivastava
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum Capital Withdrawal option | 5.37 | 23.23 | 19.67 |
| Nifty Pharma TRI | 1.87 | 20.92 | 15.42 |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
30.5996
Last change
-0.62 (-2.0265%)
Fund Size (AUM)
₹ 1,282 Cr
Performance
12.32% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Fund Manager
Meeta Shetty, Rajat Srivastava
Riskometer
HIGH
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 11.17 |
| CASH / NET CURRENT ASSET | 7.38 |
| APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/- | 7.19 |
| CIPLA LIMITED EQ NEW FV RS.2/- | 5.76 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 5.58 |
| AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/- | 5.44 |
| FORTIS HEALTHCARE LIMITED. EQ | 5.3 |
| LUPIN LIMITED EQ NEW F.V. RS.2/- | 4.58 |
| ASTER DM HEALTHCARE LIMITED EQ | 4.45 |
| WOCKHARDT LIMITED EQ FV RS. 5/- | 3.67 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 86.8 |
| Financial Services | 2.7 |
| Chemicals | 1.45 |
| Consumer Services | 0.84 |
| Information Technology | 0.52 |